MIP-3α Expression in Macrophages Is NOD Dependent by Hausmann, Martin et al.
Fax +41 61 306 12 34
E-Mail karger@karger.ch
www.karger.com
 Original Paper 
 Digestion 2012;85:192–201 
 DOI: 10.1159/000335423 
 MIP-3  Expression in Macrophages Is 
NOD Dependent 
 M. Hausmann a    C. Zeitler c    A. Weber b    M. Krebs a    S. Kellermeier a    
P. Rosenstiel e    C. de Vallière a    K. Kosovac c    M. Fried a    E. Holler d    G. Rogler a  
 a  Division of Gastroenterology and Hepatology and  b  Institute of Pathology, University Hospital of Zurich, 
 Zurich , Switzerland;  c  Department of Internal Medicine I, University of Regensburg,  d  Department of 
Haematology/Oncology, University Medical Centre,  Regensburg , and  e  Institute of Clinical Molecular Biology, 
Christian-Albrechts-University,  Kiel , Germany 
of NOD2 variants were unchanged as compared to wild-type 
patients.  Conclusion: Our data demonstrate a dose-depen-
dent increase in MIP-3  secretion in the human myeloid cell 
line MM6 upon MDP. However, MIP-3  -driven recruitment of 
Th17 cells or CD45R0 + memory T lymphocytes is not affected 
in patients carrying heterozygous NOD2 variants. 
 Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 Antigens passing over the tightly regulated intestinal 
epithelial barrier are recognized and cleared by intestinal 
macrophages (IMACs). In healthy individuals mono-
cytes differentiate into tolerant IMACs with a prototypic 
phenotype lacking activation markers such as toll-like re-
ceptors (TLRs) 2 and 4  [1] . This is important in maintain-
ing effective tolerance to the natural microbial flora thus 
preventing chronic inflammation in response to com-
mensal bacteria. Consequently no or only low activation 
of pro-inflammatory transcription factors such as nucle-
ar factor-  B (NF-  B) is found in normal mucosa  [2] . But 
normal IMACs may still express intracytoplasmatic pat-
tern recognition receptors (PRRs) such as TLR9 or NOD2. 
This enables IMACs to react to invading bacteria. NOD2 
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 Abstract 
 Background: The first identified susceptibility gene for 
Crohn’s disease,  NOD2 , acts as a sensor for the bacterial-wall 
peptidoglycan fragment muramyl dipeptide (MDP) and ac-
tivates the transcription factor nuclear factor-  B (NF-  B). 
Upon NF-  B activation, intestinal macrophages (IMACs) in-
duce expression of macrophage inflammatory protein (MIP)-
3  to attract memory T lymphocytes. We therefore investi-
gated the influence of NOD2 ligation of IMAC differentiation 
and functional MIP-3  induction.  Methods: Human embryo-
nal kidney HEK293 cells were transfected with NOD2 wild-
type (NOD2 WT ) and the NOD2 SNP13 variant (NOD2 L1007fsinsC ) 
and stimulated with MDP. Recruitment of CD45R0 + and Th17 
cells was determined by immunohistochemistry.  Results: 
Endogenous NOD2 stimulation was followed by a dose-de-
pendent increase in MIP-3  secretion in MONO-MAC-6 
(MM6) cells. MIP-3  mRNA was also significantly ( * p  ! 0.05) 
induced in HEK293 transfected with NOD2 WT via MDP liga-
tion. In vivo cell-cell contacts between IMACs and CD45R0 + 
memory T cells as well as recruitment of Th17 cells in patients 
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detects the bacterial-wall component muramyl dipeptide 
(MDP). MDP sensing via the leucine-rich repeat domain 
of NOD2 induces activation of NF-  B in monocytes/
macrophages as well as in intestinal epithelial cells  [3–6] . 
By activation of the NF-  B signaling pathway numerous 
proinflammatory genes are induced, these include inter-
leukin (IL)-1  , IL-6, IL-8, TNF, GM-CSF or chemokines 
and their receptors, such as macrophage inflammatory 
protein (MIP)-3   [7–9] .
 Variants of NOD2 were the first genetic susceptibil-
ity factors identified for Crohn’s disease (CD), an in-
flammatory bowel disease (IBD). The three most fre-
quent single-nucleotide polymorphisms (SNP) are SNP 
8, 12 and 13  [10, 11] . These SNPs are associated with in-
effective MDP binding and a subsequent inability to ac-
tivate defense mechanisms which results in reduced se-
cretion of antimicrobial peptides and chemokines and 
increased bac terial translocation in animal models  [5, 
12, 13] . Using FISH technology, we detected mucus-as-
sociated bacteria in CD patients’ mucosa but not in con-
trol specimens  [14] . Accumulation of endotoxin in the 
intestinal tissue of CD patients reflected the NOD2 
genotype: patients with heterozygous SNP8 or SNP13 
variants revealed notably stronger endotoxin staining 
than patients with SNP12 or the wild-type (WT) vari-
ant indicating more transepithelial bacterial transloca-
tion or ineffective clearance of bacterial products  [14] . 
Increased activation of NF-  B was found in the mucosa 
of CD patients, and this was even greater in patients 
with NOD2 variants  [14] .
 MIP-3  – also called liver and activation-induced 
chemokine (LARC)  [15] , Exodus  [16] or SCYA20 – is a 
CC chemokine which has been reported to attract mem-
ory T cells and immature dendritic cells (DCs)  [17–23] . 
In contrast to many other chemokines MIP-3  has a spe-
cific receptor: it binds almost exclusively to the chemo-
kine receptor CCR6, which is expressed on immature 
DCs and memory T cells, but also on B lymphocytes  [22, 
24–28] . Annunziato et al.  [29] observed the presence of 
CCR6 + IL-17-producing T cells in the gut. Epithelial cells 
are thought to be an important source of MIP-3  pro-
duction  [16] . Other cell types, such as endothelial cells, 
fibroblasts, and monocytes are also known to express 
MIP-3   [28, 30] . High MIP-3  mRNA and protein ex-
pression are induced during the specific differentiation 
of IMACs as shown in previous studies from our labora-
tory  [31] . Similarly, MIP-3  mRNA was found to be 
highly expressed in differentiated macrophages in the 
lung  [28] . Izadpanah et al.  [32] demonstrated constitu-
tive MIP-3  mRNA expression in intestinal epithelium 
and an upregulation by pro-inflammatory cytokines or 
in response to infection with bacterial pathogens. Kwon 
et al.  [33] found significantly elevated MIP-3  mRNA 
and protein levels in CD patients compared with controls 
or ulcerative colitis (UC) patients. CCR6 expression in T 
cells and chemotactic response to MIP-3  is thought to 
be restricted to the CD45R0 + memory T cell population 
 [27] . These data suggest that CCR6 functions on memo-
ry T cells that home to mucosal sites as part of an im-
mune response  [26] . Professional antigen-presenting and 
MIP-3  -secreting IMACs may serve as a contact point 
for CD45R0 + memory T and B cells and subpopulations 
of DCs  [31] .
 As translocated bacterial components can activate 
NF-  B in a NOD2 genotype-specific manner, we hy-
pothesized that a lack of detection of invading bacteria 
or bacterial material could be followed by impaired re-
cruitment of MIP-3  -dependent lymphocytes in indi-
viduals with NOD2 variants. The aim of the study was 
therefore to establish a link between NOD2-mediated 
MIP-3  expression and lymphocyte recruitment in CD 
patients.
 Materials and Methods 
 Patients 
 Primary human cells were obtained from surgical specimens 
taken from healthy areas of the mucosa of patients undergoing 
surgery for colorectal carcinoma or from the mucosa of patients 
with CD. Histology was performed on surgical specimens by a 
pathologist. The medical treatment of the patients is listed in 
 online supplementary table 1 (for all online suppl. material, see 
www.karger.com/doi/10.1159/000335423). Of a total of 43 sub-
jects, 18 were male and 25 were female. The patients were between 
16 and 74 (mean 43.2  8 13.8) years of age and treated with 
budesonide, 5-ASA, azathioprine and systemic steroids. The dif-
ferent pharmacotherapies had no apparent influence on the re-
sults of our assays as analyzed by clustering disease, treatment 
and gene variations. One-way ANOVA and post-hoc Bonferroni 
test were applied for analysis. This study was approved by the Eth-
ics Committees of the University of Regensburg and the Univer-
sity of Zurich and performed in accordance with the Declaration 
of Helsinki.
 Cell Lines and Primary Cells 
 The human embryonal kidney (HEK)293 cell line and the hu-
man acute monocytic leukemia cell line MONO-MAC-6 (MM6) 
were cultured under standard tissue culture conditions as de-
scribed previously  [34] . Surgical specimens from inflamed and 
normal mucosa were obtained by surgery. The study was ap-
proved by the University of Regensburg Ethics Committee. Spec-
imens were obtained from the colons of patients after their agree-
ment. Primary cells were isolated from surgical specimens as de-
scribed  [35, 36] . Briefly, intestinal epithelial cells were isolat-
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ed from surgical specimens. Mucosal strips were incubated in 
1 mmol/l EDTA (Sigma) for 10 min at 37   °   C and transferred to 
tubes. Tubes were shaken vigorously 5–10 times. Mucosal strips 
were removed by passing the slurry over a coarse mesh (400   m; 
Carl Roth GmbH, Karlsruhe, Germany). The suspension contain-
ing the detached intestinal epithelial cells was passed over the 
mesh filter (80-  m pore size; Sefar, Kansas City, Mo., USA), and 
intact CEC crypts were eluted by inverting the filter in serum-free 
culture medium (keratinocyte serum-free medium; Gibco-BRL, 
Eggenstein, Germany).
 Specimens for isolation of human lamina propria mononuclear 
cells (LPMNCs) were incubated for 30 min in 2 ml phosphate-buff-
ered saline (PBS) with 1 mg/ml collagenase type I (= 336 U/ml), 0.3 
mg/ml deoxyribonuclease (DNase I, Boehringer, Mann heim, Ger-
many) and 0.2 mg/ml hyaluronidase without fetal calf serum (FCS) 
at 37  °  C. Cells were dispersed by passing through a 27-gauge needle 
by a 1- to 2-ml syringe, washed in 1.5 ml PBS with 500   l FCS and 
finally submitted to Ficoll density gradient centrifugation for 20 
min at 2,000 rpm ( ; 690  g , without brake) in a Heraeus centrifuge 
for the isolation of mononuclear cells. The interphase was care-
fully removed and washed with PBS. Intestinal macrophages were 
labeled with immunomagnetic microbeads armed with CD33 an-
tibody and purified twice with the help of type AS separation col-
umns (Miltenyi Biotec) as described previously  [37] .
 Peripheral blood lymphocytes and blood monocytes (CD33 + ) 
were isolated from healthy volunteers as described previously 
 [36] . The purity of isolated primary cells was always  1 95%.
 RNA Extraction and Quantitative Real-Time PCR 
 Total RNA was isolated using the RNeasy Mini Kit (#74106, 
Qiagen) following the manufacturer’s recommendations. cDNA 
was synthesized with a high-capacity cDNA reverse-transcrip-
tion kit according to the manufacturer’s instructions (#4368814, 
Applied Biosystems). To determine expression, quantitative real-
time PCR (qPCR) was performed under the following cycling 
conditions: 20 s at 95  °   C, then 45 cycles of 95  °   C for 3 s and 60   °   C 
for 30 s with the TaqMan Fast Universal Mastermix. Primers for 
real time PCR: MIP-3  for 5  TGT CAG TGC TGC TAC TCC 
ACC T 3  , MIP-3  rev 5  CTG TGT ATC CAA GAC AGC AGT 
CAA 3  , MIP-3  probe, 6-FAM-5  TGC GGC GAA TCA GAA 
GCA GCA A 3  -TAMRA. Human IL-8 (#Hs00174103_m1, PE Ap-
plied Biosystems) and GAPDH (#4326317E, PE Applied Biosys-
tems). Each sample was analyzed in triplicate. The comparative 
   C t method was applied to determine the quantity of the target 
sequences relative to the endogenous control GAPDH and a refer-
ence sample.
 ELISA 
 Culture supernatants from MM6 and HEK293 cells were col-
lected after MDP (#A9519, Sigma-Aldrich, Steinheim, Germany) 
or lipopolysaccharide (LPS) (#62325, Fluka, Buchs, Switzerland) 
stimulation. The supernatants were centrifuged and used for de-
termination of IL-8 and MIP-3  by commercially available ELISA 
kits (human IL-8 colorimetric ELISA kit, Pierce, Rockford, Ill., 
USA and human CCL20/MIP-3  quantikine ELISA kit, R&D 
Systems, Minneappolis, Minn., USA, respectively).
 Vectors, Transfection and Stimulation 
 For transfection 7.5  ! 10 5 HEK293 were seeded in each well 
of a 6-well plate (Corning Inc., Costar  ) in 1.5-ml media. Cells 
were cultured under standard tissue culture conditions as de-
scribed above until cells were 60–80% confluent. pcDNA3.1 
plasmids with inserts were constructed as described else-
where  [38] . For transient transfection, we used 2-  g expression 
vectors for NOD2 WT gene (pcDNA3.1_NOD2/CARD15) and for 
NOD2 SNP13 variant (pcDNA3.1_SNP13). The control vector 
(pcDNA3.1) was from Invitrogen, Carlsbad, USA. Expression 
vectors were diluted in 97   l serum-free media in sterile 1.5-ml 
plastic tubes. 3   l Fugene 6 TM (Roche) was added, mixed and in-
cubated for 10 min at room temperature. The Fugene TM -DNA 
mixture was added to the wells in a drop-wise manner. For trans-
fection control cells were transfected with 2   g pEGFP vector (BD 
Biosciences) in a separate well. Transfected cells were incubated 
for 24 h. For stimulation with MDP (#A9519, Sigma) substance 
was diluted in 97   l serum-free media in sterile 1.5-ml plastic 
tubes. 3   l Fugene 6 TM (Roche) were added, mixed and incubated 
for 10 min at room temperature. The Fugene TM -MDP mixture was 
added to the wells in a drop-wise manner. For stimulation with 
LPS (#62325, Fluka) substance was diluted in media containing 
serum in sterile 1.5-ml plastic tubes. Experiments with transfect-
ed HEK293 were terminated after 72 h.
 Antibodies 
 For the identification of human IMACs in immunohisto-
chemistry, mouse anti-human macrophage CD68 (M0814, clone 
KP1, IgG 1  , monoclonal, DAKO, Hamburg, Germany, final con-
centration 0.5   g/ml) was applied. Mouse anti-human CD45R0 
(M 0742, clone UCHL1, IgG2a, monoclonal, DAKO, final con-
centration 0.2   g/ml) was used to identify human memory cells. 
Goat anti-human IL-17 (AF-317-NA, IgG, R&D Systems, dilution 
1: 100) was applied for the identification of human IL-17-positive 
cells.
 Monoclonal mouse anti-human NOD2 (#114445, IgG, Cay-
man Chemical, Ann Arbor, Mich., USA, dilution 1: 1000) and 
monoclonal mouse anti-human actin (#25060051, IgG1  , Chem-
icon International, Temecula, Calif., USA, dilution 1: 1,000) were 
used for Western blots.
 Peroxidase-conjugated goat anti-mouse IgG antibody (A-
4416, Sigma, final concentration 0.2   g/ml) or rabbit anti-goat 
(P0449, DAKO, dilution 1: 300) was used as secondary antibody 
in immunohistochemistry and goat anti-mouse IgG antibody 
(#sc-2005, Santa Cruz, Heidelberg, dilution 1: 5,000) as secondary 
antibody in Western blotting.
 Immunohistochemistry 
 Surgical specimens in paraffin blocks were cut (5   m) and 
mounted on superfrost slides (Menzel-Gläser, Braunschweig, 
Germany). Sections were deparaffinized in xylene and gradually 
hydrated. The slides were exposed to 0.3% hydrogen peroxide in 
PBS for 5 min to inactivate endogenous peroxidase. Sections were 
treated using the Bond-maX automated staining system (Leica 
Microsystems). For brown staining, the primary antibody was de-
tected using the Refine DAB method (Vision BioSystems) with an 
H 2 Buffer (Vision BioSystems) heat-induced epitope retrieval 
(98  °  C). For red staining, the primary antibody was detected using 
alkaline phosphatase polymer and new Fuchsine as substrate. 
Slides were counterstained with hematoxylin, dehydrated and 
mounted.
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
ts
bi
bl
io
th
ek
, R
eg
en
sb
ur
g
13
2.
19
9.
14
5.
19
5 
- 1
0/
23
/2
01
9 
12
:2
2:
18
 P
M
 NOD Ligation Stimulates Expression of 
MIP-3  
Digestion 2012;85:192–201 195
 Statistical Analyses 
 Statistical analyses were performed using PASW statistics 18.0 
(SPSS Inc., USA). One-way ANOVA and post-hoc Bonferroni test 
were applied for analysis of human samples. One-way ANOVA 
and Kruskal-Wallis one-way ANOVA on ranks were used for pri-
mary human cell experiments and human cell lines. Bars repre-
sent mean values with Whiskers displaying standard deviation. 
Differences were considered significant at p  ! 0.05 (cytokine and 
chemokine levels, quantification of immunohistochemistry). Lu-
minescence of Western blots was quantified densitometrically 
with OptiQuant (Packard Instrument, USA). For quantitative 
analysis of cell recruitment in the intestinal mucosa and expres-
sion of CD68-, CD45R0- and IL-17-positive cells were counted 
and calculated from four high-power fields (hpf) at a magnifica-
tion of  ! 200.
 Results 
 MDP-Induced MIP-3  Expression in the Myeloid Cell 
Line MM6 
 We hypothesized that NOD2 stimulation via MDP is 
followed by increased MIP-3  secretion in IMACs. To 
investigate the influence of NOD2-mediated NF-  B acti-
vation on MIP-3  expression, we examined its induction 
in the human myeloid cell line MM6. As positive control 
IL-8 secretion upon LPS stimulation was confirmed for 
MM6 cells (online suppl. fig. 1). We stimulated MM6 with 
0, 0.001, 0.01, 0.1, 1, 10 and 100   g/ml MDP. MIP-3  se-
cretion was induced after 8 h stimulation in a dose-de-
pendent manner ( fig. 1 ). This confirmed our hypothesis 
that MDP stimulates MIP-3  secretion in myeloid cells. 
To cross-check our hypothesis we examined MIP-3  in-
duction upon MDP stimulation in the NOD2 negative 
cell line HEK293T. HEK293T cells were stimulated in a 
single experiment for 24 h with 1   g/ml MDP. No induc-
tion of MIP-3  and IL-8 secretion was obtained com-
pared to nonstimulated cells (not shown).
 NOD2 Variants Impair MDP-Mediated MIP-3  
Induction 
 To investigate the influence of NOD2 on the expres-
sion of MIP-3  , we transfected HEK293T with SNP13 
variants. One variant expressed the NOD2 WT gene 
(pcDNA3.1_NOD2/CARD15) and the second expressed 
the NOD2 SNP13 variant (pcDNA3.1_SNP13). The ‘emp-
ty’ vector backbone served as control (pcDNA3.1). NOD2 
expression in transiently transfected HEK293T was con-
firmed by Western blot (online suppl. fig. 2). Cells were 
stimulated with MDP. To confirm NF-  B activation IL-8 
secretion was measured (not shown). MIP-3  expression 
was significantly (p  ! 0.05) induced by 1,000 ng/ml MDP 
stimulation ( fig.  2 ). We also determined increased ex-
pression of MIP-3  mRNA upon expression of NOD2 
SNP13 variant compared to vector control.
 NOD2-dependent secretion of MIP-3  into the super-
natant was also confirmed by ELISA. Cells expressing the 
control plasmid did not show any changes in basal MIP-
3  secretion. Expression of both NOD2 WT gene and 
NOD2 SNP13 variant resulted in a significantly (p  ! 0.05) 
elevated MIP-3  secretion (6.2- and 3.2-fold compared to 
control, respectively;  fig. 3 ). MIP-3  mRNA expression 
was significantly (p  ! 0.05) induced by 100 ng/ml MDP 
stimulation for NOD2 WT gene (19.9-fold compared to 
unstimulated cells also transfected with NOD2 WT gene; 
 fig. 3 ). Higher MDP concentrations led to an increase in 
the secretion of MIP-3  in NOD2 SNP13 variant trans-
fected HEK293T, achieving the values for NOD2 WT gene 
following MDP stimulation with 1,000 and 2,000 ng/ml 
MDP. These results confirmed our hypothesis that MDP 
stimulates MIP-3  secretion in a NOD2 variant-depen-
dent manner.
 MIP-3  mRNA Expression in Human Intestinal 
Mucosa 
 Previously, in an ex vivo  model, we demonstrated that 
induction of MIP-3  during differentiation of human 
IMACs is followed by increased migration of CD45R0 + T 
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 Fig. 1. MIP-3  secretion of MM6 incubated with MDP. MM6 were 
stimulated with increasing concentrations of MDP or vehicle 
alone. MIP-3  secretion was quantified in the supernatant of 
these cells by ELISA. Dose-dependent secretion of MIP-3  during 
8 h stimulation confirmed our hypothesis that MDP stimulates 
MIP-3  secretion in myeloid cells. Data were calculated from 
three independent experiments and are given as mean (SD). 
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cells. We hypothesized that MIP-3  expression is also in-
duced in IMACs in vivo during their differentiation in the 
lamina propria followed by the recruitment of CCR6 + 
cells. To confirm this hypothesis, MIP-3  mRNA expres-
sion was determined by real-time PCR in primary intes-
tinal epithelial cells, LPMNCs and IMACs isolated from 
human intestinal mucosa from surgical specimens. To 
keep procedures similar, monocytes and intestinal mac-
rophages were isolated via CD33, a unique surface marker 
present on both. Real-time PCR for MIP-3  mRNA syn-
thesis showed high expression levels for both intestinal 
epithelial cells (17.6  8 1.1 relative to blood lymphocytes 
set as one;  fig. 4 ) and IMACs (12.4  8 0.9). Similar MIP-3  
mRNA expression levels were obtained from LPMNCs, 
including IMACs (11.9  8 1.1). LPMNCs depleted of 
IMACs showed low MIP-3  mRNA expression levels (6.1 
 8 1.1). Levels of MIP-3  mRNA synthesis found in pe-
ripheral blood lymphocytes were set as one and used as 
the control ( fig. 4 ). Similarly, the level of MIP-3  mRNA 
expression was obtained from human blood monocytes 
isolated from peripheral blood lymphocytes (0  8 0.5).
 Recruitment of CD45R0 +  and Th17 Cells Is Not 
Affected by Heterozygous NOD2 Gene Variants 
 Breakdown of the epithelial barrier and successive in-
flux of bacterial wall components seem to play an essen-
tial role in the pathogenesis of CD. In vitro MDP is able 
to activate the NF-  B pathway via NOD2 followed by the 
release of MIP-3  , resulting in memory T lymphocyte 
recruitment. The in vitro experiments described above 
showed a functional deficit in MIP-3  expression in cells 
transfected with NOD2 variant SNP13. Since MIP-3  
may be involved in the aggregation of CCR6 + lympho-
cytes during an immune response, we consequently in-
vestigated the recruitment of CD45R0 + cells and Th17 
cells with respect to NOD2 genotypes. Immunohisto-
chemistry showed that cell-cell contacts between IMACs 
and CD45R0 + memory T cells showed no difference be-
tween patients with NOD2 WT gene (34.7  8 17.8 cells/hpf) 
and patients with heterozygous mutations in NOD2 (31.8 
 8 16.4 for SNP8, 53.0  8 26.4 for SNP12, and 41.5  8 20.2 
cells/hpf for SNP13;  fig. 5 ). Recruitment of Th17 cells was 
unchanged in patients with NOD2 WT (12.5  8 12.8 cells/
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 Fig. 2. Levels of MIP-3  mRNA in MDP-stimulated HEK293T. 
HEK293T were transiently transfected with pcDNA3.1 (control, 
white column), pcDNA3.1_NOD2/CARD15 (NOD2/CARD15 
WT gene, light grey column) or pcDNA3.1_SNP13 (NOD2/
CARD15 mutation SNP13, dark grey column) and stimulated 
with increasing concentrations of MDP. Real-time PCR shows 
that overexpression of both NOD2 and NOD2 SNP13 gene vari-
ants resulted in increased MIP-3  mRNA. The expression of the 
WT gene led to a significant ( *  p  ! 0.05) induction of MIP-3  
mRNA by stimulation with 1,000 ng/ml MDP compared to un-
stimulated cells. Data were calculated from four independent ex-
periments and are given as mean (SD). One-way ANOVA and 
Kruskal-Wallis one-way ANOVA on ranks were used. 
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 Fig. 3. ELISA: Secretion of MIP-3  in MDP stimulated HEK293T. 
HEK293T were transiently transfected with pcDNA3.1 (control), 
pcDNA3.1_NOD2/CARD15 (NOD2/CARD15 WT gene) or 
pcDNA3.1_SNP13 (NOD2/CARD15 mutation SNP13) and stim-
ulated with increasing concentrations of MDP. Overexpression of 
both NOD2 gene variants resulted in an increased MIP-3  pro-
duction. The expression of the WT gene led to a significant ( *  p  ! 
0.05) induction of MIP-3  secretion by stimulation with 100 ng/
ml MDP compared to the empty vector. Data were calculated 
from three independent experiments and are given as mean (SD). 
One-way ANOVA and Kruskal-Wallis one-way ANOVA on ranks 
were used. 
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hpf) and patients with heterozygous mutations in NOD2 
(12.4  8 7.7 for SNP8, 14.2  8 4.3 for SNP12, and 20.0  8 
12.1 cells/hpf for SNP13;  fig. 6 ).
 Discussion 
 Disturbance of the mucosal barrier and mucosal 
transport processes is thought to be a major factor in the 
pathogenesis of intestinal inflammation and IBD. In-
creased permeability of the epithelial barrier in ulcerative 
colitis and CD has been reported  [39–42] . Local protec-
tion mechanisms of the healthy mucosa prevent the inva-
sion of bacteria or specific pathogens from the intestinal 
lumen into the body. Protective factors such as mucus 
production  [43] and synthesis of antimicrobial peptides 
are impaired in CD. The intestinal barrier becomes 
‘leaky’, resulting in the invasion of luminal antigen. A 
number of knockout models of IBD confirm that bacteria 
are essential for the development of intestinal inflamma-
tion  [44–46] . NOD2 is an intracellular sensor of bacterial 
MDP that has been shown to be the most important sus-
ceptibility factor for the onset and pathogenesis of CD. 
NOD2 is able to activate the NF-  B pathway followed by 
the release of MIP-3  , which attracts memory T lympho-
cytes  [17–23] .
 In this study, we therefore asked (1) whether the ex-
pression of MIP-3  is associated with the NOD2 geno-
type and (2) what consequence stimulation with bacte-
rial antigen after mucosal translocation has on recruit-
ment of CCR6-positive immune cells.
 We found that NOD2 stimulation via MDP was fol-
lowed by a dose-dependent increase in MIP-3  secretion 
in the myeloid cell line MM6. No induction of MIP-3  
secretion was obtained in NOD2-negative HEK293 upon 
MDP stimulation but in vitro , MIP-3  mRNA was sig-
nificantly (p  ! 0.05) induced in HEK293 transfected with 
NOD2_pcDNA via MDP ligation. Increased MIP-3  
protein secretion was confirmed by ELISA. In vivo, MIP-
3  protein expression in human intestinal epithelial cells 
and IMACs was determined in a nonquantitative manner 
by immunohistochemistry and flow cytometry  [31] . In 
this work, we could confirm  MIP-3  mRNA expression 
ex vivo in freshly isolated intestinal epithelial cells and 
IMACs. MIP-3  mRNA expression was significantly 
(p  ! 0.05) higher in primary human IMACs in compari-
son to monocytes. Previous in vitro experiments showed 
a functional deficit in Mip-3  expression in HEK293 
cells transfected with NOD2 variant SNP13. We therefore 
investigated Th17 and memory cell recruitment with re-
spect to NOD2 variants. In vivo cell-cell contacts be-
tween IMACs and CD45R0 + and recruitment of Th17 
cells was unchanged in patients with heterozygous NOD2 
variants as compared to NOD2 WT individuals.
 Altered immunological responses in the gut during 
inflammation and under normal conditions are reflected 
by different PRR subsets of IMACs and DCs. It seems un-
likely that in CD only a single reactive endotoxin compo-
nent accumulates in the mucosa. Multiple pathogen-as-
sociated molecular patterns or microbe-associated mo-
lecular patterns are detected by a number of PRRs shown 
to be expressed extracellularly. Intracellularly, a reper-
toire of PRRs accounts for NF-  B-driven immunological 
competence of IMACs and DCs during inflammation. 
Recognition of endotoxin induces a Th1 or Th17 pro-
inflammatory immune response directed normally at 
pathogens  [47–49] . Due to their expansion or homing 
Th17 cells are highly enriched in the intestine. Th17 cells 
express various trafficking receptors, but the MIP-3  re-
ceptor CCR6 is uniformly expressed by all subsets of 
Th17 cells. In mice, CCR6 –/– Th17 cells are less efficient 
in migration to small intestinal lamina propria  [50] . 
Short-term migration of CCR6 –/– Th17 cells to the large 
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 Fig. 4. MIP-3  mRNA expression determined by real-time PCR. 
Cells were isolated as described in ‘Materials and Methods’. Pe-
ripheral blood lymphocytes were set as zero. Differentiation of 
monocytes from the peripheral blood into IMACs led to a sig-
nificant ( *  p  ! 0.05) induction of MIP-3  mRNA expression. Sim-
ilar expression levels were found in intestinal epithelial cells. Ex-
pression data are given relative to a representative blood mono-
cyte sample set to zero. One-way ANOVA, Kruskal-Wallis 
one-way ANOVA on ranks. 
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intestine is not decreased. However, significantly few-
er Th17 cells and an aberrant increase of Th1 cells are 
found in the intestine of Rag1 –/– SCID mice injected with 
CCR6 –/– Th17 cells compared to WT Th17 cells. Consis-
tently, CCR6 –/– Th17 cells induce more severe intestinal 
inflammation in Rag1 –/– SCID mice  [50] . CCR6 is not the 
only trafficking receptor that is important for migration 
and localization in the gut.
 On the other hand, under normal conditions, ‘tolerant’ 
IMACs and DCs lack antigens connected with the recep-
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 ! 200.  e Recruitment of CD45R0+ memory T cells (white columns) and cell-cell-contacts between memory T 
cells and IMACs (grey columns). Cells were counted in four high-power fields. One-way ANOVA and post-hoc 
Bonferroni test were applied for analysis. 
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